Mingfeng Han

InstitutionThe Second Hospital of Fuyang
AddressFuyang
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 18 Covid-19 publications, with a maximum of 4 publications in April 2020
    All Publications
    Bar chart showing 20 publications over 3 distinct years, with a maximum of 14 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jia Z, Yan X, Gao L, Ding S, Bai Y, Zheng Y, Cui Y, Wang X, Li J, Lu G, Xu Y, Zhang X, Li J, Chen N, Shang Y, Han M, Liu J, Zhou H, Li C, Lu W, Liu J, Liu J, Wang L, Fan Q, Wu J, Shen H, Jiao R, Chen C, Gao X, Tian M, Lu W, Yang Y, Wong GW, Wang T, Jin R, Shen A, Xu B, Shen K. Comparison of Clinical Characteristics Among COVID-19 and Non-COVID-19 Pediatric Pneumonias: A Multicenter Cross-Sectional Study. Front Cell Infect Microbiol. 2021; 11:663884. PMID: 34277466.
      Citations: 1     Fields:    Translation:Humans
    2. Pan M, Wang RR, Chen X, Han J, Li Q, Miao M, Rao J, Huang J, Yu L, Xu Y, Li L, Shao Q, Ma H, Han M, Fan X. Laboratory predictors of severe Coronavirus Disease 2019 and lung function in followed-up. Clin Respir J. 2021 Aug; 15(8):904-914. PMID: 33896114.
      Citations:    Fields:    Translation:Humans
    3. Li S, Duan X, Li Y, Li M, Gao Y, Li T, Li S, Tan L, Shao T, Jeyarajan AJ, Chen L, Han M, Lin W, Li X. Differentially expressed immune response genes in COVID-19 patients based on disease severity. Aging (Albany NY). 2021 03 29; 13(7):9265-9276. PMID: 33780352.
      Citations: 2     Fields:    Translation:HumansCells
    4. Wang D, Fu B, Peng Z, Yang D, Han M, Li M, Yang Y, Yang T, Sun L, Li W, Shi W, Yao X, Ma Y, Xu F, Wang X, Chen J, Xia D, Sun Y, Dong L, Wang J, Zhu X, Zhang M, Zhou Y, Pan A, Hu X, Mei X, Wei H, Xu X. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial. Front Med. 2021 Jun; 15(3):486-494. PMID: 33687643.
      Citations: 10     Fields:    Translation:Humans
    5. Zhang Y, Wang C, Han M, Ye J, Gao Y, Liu Z, He T, Li T, Xu M, Zhou L, Zou G, Lu M, Zhang Z. Correction to: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference. Virol Sin. 2020 Dec; 35(6):885-886. PMID: 32955691.
      Citations: 2     Fields:    
    6. Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients. Proc Natl Acad Sci U S A. 2020 12 08; 117(49):30898-30899. PMID: 33203670.
      Citations:    Fields:    Translation:Humans
    7. Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30027-30028. PMID: 33184171.
      Citations:    Fields:    Translation:HumansPHPublic Health
    8. Li L, Sun W, Han M, Ying Y, Wang Q. A Study on the Predictors of Disease Severity of COVID-19. Med Sci Monit. 2020 Sep 23; 26:e927167. PMID: 32963215.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    9. Han M, Xu M, Zhang Y, Liu Z, Li S, He T, Li J, Gao Y, Liu W, Li T, Chen Z, Huang X, Cheng G, Wang J, Dittmer U, Witzke O, Zou G, Li X, Lu M, Zhang Z. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity. Med Microbiol Immunol. 2020 Dec; 209(6):657-668. PMID: 32860073.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    10. Zhang Y, Wang C, Han M, Ye J, Gao Y, Liu Z, He T, Li T, Xu M, Zhou L, Zou G, Lu M, Zhang Z. Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference. Virol Sin. 2020 Dec; 35(6):758-767. PMID: 32749593.
      Citations: 5     Fields:    Translation:Humans
    11. Li S, Li J, Zhang Z, Tan L, Shao T, Li M, Li X, Holmes JA, Lin W, Han M. COVID-19 induced liver function abnormality associates with age. Aging (Albany NY). 2020 07 28; 12(14):13895-13904. PMID: 32721928.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    12. Zha L, Shen Y, Pan L, Han M, Yang G, Teng X, Tefsen B. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19. J Infect. 2021 Jan; 82(1):159-198. PMID: 32473229.
      Citations: 9     Fields:    Translation:Humans
    13. Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, Liu Q, Song Y, Li X, Duan Z, Zheng Q, Yang Z, Liang J, Han M, Ruan L, Wu C, Zhang Y, Jia ZH, Zhong NS. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine. 2021 May; 85:153242. PMID: 33867046.
      Citations: 120     Fields:    Translation:Humans
    14. Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W, Wu Y, Xiao W, Liu S, Chen E, Chen W, Wang X, Yang J, Lin J, Zhao Q, Yan Y, Xie Z, Li D, Yang Y, Liu L, Qu J, Ning G, Shi G, Xie Q. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020 05 14; 369:m1849. PMID: 32409561.
      Citations: 385     Fields:    Translation:HumansPHPublic Health
    15. Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020 05 19; 117(20):10970-10975. PMID: 32350134.
      Citations: 963     Fields:    Translation:HumansCellsPHPublic Health
    16. Wang R, Pan M, Zhang X, Han M, Fan X, Zhao F, Miao M, Xu J, Guan M, Deng X, Chen X, Shen L. Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. 2020 Jun; 95:421-428. PMID: 32289565.
      Citations: 86     Fields:    Translation:HumansCellsPHPublic Health
    17. Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Zhu Y, Liu Y, Wang X, Wang L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020 07; 92(7):791-796. PMID: 32181911.
      Citations: 324     Fields:    Translation:HumansCellsPHPublic Health
    18. Xu J, Zhao F, Han M, Ma L, Zhang T. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr; 32(4):401-406. PMID: 32527341.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    Han's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (82)
    Explore
    _
    Co-Authors (203)
    Explore
    _
    Similar People (60)
    Explore
    _